Recommended Follow-Up Schedule | Timepoint | Assessments | |-----------|-------------| | 4 weeks post-stop | Weight, waist circumference, appetite assessment | | 8 weeks post-stop | Fasting glucose, lipid panel, blood pressure | | 12 weeks post-stop | Full metabolic panel, weight trajectory review, decision point for restarting | | 6 months post-stop | Comprehensive reassessment including HbA1c if applicable | When to Restart The Obesity Medicine Association clinical practice statements recommend re-initiating pharmacotherapy if a patient regains more than 5% of their lost weight within 6 months of stopping, particularly if comorbidities worsen [11]
By morning, the acute phase has passed, and what remains is the more manageable, lower-grade bloating or mild queasiness that most people can tolerate through a normal day
In 2025, I was riding high
The most common side effects were nausea, constipation, and diarrhea , and they were generally mild to moderate in severity
Although GLP-1s are meant to be a forever medication, there might come a time when you need to wind down your relationship with the med
It extends all the way to yours, right down to the finest details of your experimental protocol
